Since our founding in 2014, EXIAS Medical has evolved into a dynamic company driven by a passionate team that blends the energy of young talent with the experience of seasoned experts.
ROOTED IN EXPERIENCE
DRIVEN BY INNOVATION
What many may not know is that EXIAS Medical builds on the strong legacy of AVL Medical, the former MedTech division of AVL. Based in Graz, Austria, AVL Medical pioneered in-vitro diagnostics from the late 1970s through the end of the 20th century, laying the groundwork for cutting-edge advancements in the field. Leveraging their experience at AVL Medical, our founding team brought decades of expertise to EXIAS, a name that literally means Excellence In Analytical Systems.
In 2024, we proudly celebrated 10 years of EXIAS Medical – a decade of expertise, innovation, and groundbreaking achievements. Discover the journey behind EXIAS Medical from our beginnings, challenges, and the knowledge that drives innovation.
2014
Foundation of EXIAS Medical GmbH in Graz
2015-2019
From concept to market
Development of the e|1 Electrolyte Analyzer (design, software, sensor technology)
Clinical studies & beta testing
Implementation of quality management system
CE mark approval
2019
Official launch of the EXIAS e|1 Electrolyte Analyzer
2021
m|1 ISE module pilot and prototype development
2021-2023
Market refinements & IVDR certification
Shelf-life extension (from 6-9 months)
In-use extension for 150 and 300 cartridges
New sample type: urine (undiluted)
IVDR certification
2024
10-year anniversary
Today
Active sales in over 80 countries and growing global partnerships
